A judge has ordered an employee at Bayer's US subsidiary to hand over documents and computer files to the court in a lawsuit brought by Baxter alleging industrial espionage.
Gopal Dasari, a former Baxter employee who joined Bayer earlier this year, stands accused of copying trade secrets relating to the manufacturing processes used for a number of Baxter's biopharmaceutical products.
Judge Jeffrey White ordered Bayer not to copy or review any files on Dasari's computers, according to a Bloomberg report.
Dasari worked for Baxter for approximately six years and during that time was involved in a number of projects, including one to improve the manufacturing process for the firm's billion-dollar haemophilia treatment Recombinate (antihaemophilic factor). Bayer manufactures a rival product called Kogenate (recombinant Factor VIII).
Baxter is also seeking damages for its actual losses, plus punitive damages and triple damages under California's trade secrets statute.
Meantime, Baxter has been granted US approval for a new plasma- and albumin-free formulation of recombinant antihaemophilic factor called Advate. It is produced in genetically engineered Chinese hamster ovary cells that have been altered to produce factor VIII.